Resverlogix Corp. (TSE:RVX – Get Free Report) shares crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$0.05 and traded as high as C$0.05. Resverlogix shares last traded at C$0.05, with a volume of 3,000 shares.
Resverlogix Stock Performance
The stock has a market cap of C$8.91 million, a price-to-earnings ratio of -2.23 and a beta of 0.71. The company has a current ratio of 0.13, a quick ratio of 0.04 and a debt-to-equity ratio of -10.95. The stock’s 50-day moving average is C$0.05 and its 200-day moving average is C$0.06.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Articles
- Five stocks we like better than Resverlogix
- What is Forex and How Does it Work?
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Stock Average Calculator
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
